公司资料
CohBar 股价、新闻与催化剂
- 股票代码:
- CWBR
- 交易所:
- NASDAQ
- 行业:
- Biopharma
- 所在地:
- United States
股价为何变动
目前无法获取 CWBR 的收盘价变动背景。
公司概览
业务概览
CohBar was a biotechnology company focused on mitochondria and aging biology before becoming a historical ticker. Its story reflected the challenge of turning aging-related science into a practical therapeutic thesis.
所在地与行业分类
CohBar was headquartered in the United States and traded on NASDAQ. It sat in the platform-biotech and longevity research segment.
商业模式特征
The business depended on preclinical validation, translational progress, and strategic funding. Investors historically watched whether the platform could move from concept to clinical relevance.
生物医药行业定位
CohBar belongs in the historical longevity-biotech bucket. It was a science-heavy story where the market needed convincing evidence before assigning durable value.
未来催化剂
- CohBar is a legacy / closeout story now, so the catalysts are any strategic or asset-resolution update rather than a live pipeline event. The market is mainly focused on what remains.
近期新闻
新闻标题由机器翻译，详情为英文原文。
相似股票
商业成熟度、治疗领域或催化剂模式相近的同行公司。